Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YUJIRO TAKAI
Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC With EGFR Mutation
Cancer Genomics and Proteomics
Medicine
Biochemistry
Genetics
Molecular Biology
Cancer Research
Related publications
Phase I Study of Vorinostat With Gefitinib in BIM Deletion Polymorphism/Egfr Mutation Double‐positive Lung Cancer
Cancer Science
Cancer Research
Medicine
Oncology
P091 Association Between BIM Polymorphism and Lung Cancer Outcomes: A Meta-Analysis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Effect of BIM Deletion Polymorphism on Intrinsic Resistance and Clinical Outcome of Cancer Patient With Kinase Inhibitor Therapy
Scientific Reports
Multidisciplinary
Participatory Design With BIM
Environment-Behaviour Proceedings Journal
Combination of EGFR-TKIs With Chemotherapy Versus Chemotherapy or EGFR-TKIs Alone in Advanced NSCLC Patients With EGFR Mutation
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Clinical Features of Bim Deletion Polymorphism and Its Relation With Crizotinib Primary Resistance in Chinese Patients With ALK /ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
MA15.05 the Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association With Primary Response to EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
BIM Policy and Management
Construction Management and Economics
Building
Construction
Management Information Systems
Manufacturing Engineering
Industrial
P061 Real Clinical Practice of Using Immunotherapy in NSCLC Patients With EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
